Brainstorm cell therapeutics to provide update on nurown program

A conference call and webcast will be held tomorrow, april 9, at 8:00 a.m. eastern time new york , april 8, 2024 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference call to update shareholders on the nurown® program tomorrow, april 9, at 8:00 am eastern time.
BCLI Ratings Summary
BCLI Quant Ranking